These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10421970)

  • 21. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase.
    Worrall NK; Lazenby WD; Misko TP; Lin TS; Rodi CP; Manning PT; Tilton RG; Williamson JR; Ferguson TB
    J Exp Med; 1995 Jan; 181(1):63-70. PubMed ID: 7528779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centered complexes in allogeneic, heterotopic cardiac transplants: effects of treatment with pyrrolidine dithiocarbamate.
    Nakanishi AL; Roza AM; Adams MB; Seibel R; Moore-Hilton G; Kalyanaraman B; Pieper GM
    Free Radic Biol Med; 1998 Jul; 25(2):201-7. PubMed ID: 9667497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial nitric oxide synthase gene-expression and endothelial function in chronic rejection after cardiac transplantation.
    Wildhirt SM; Weis M; Schulze C; Conrad N; Rieder G; Enders G; Meiser B; Kornberg A; Reichenspurner H; von Scheidt W; Reichart B
    Transplant Proc; 1999; 31(1-2):96-8. PubMed ID: 10083026
    [No Abstract]   [Full Text] [Related]  

  • 24. NO control: nitric oxide directly regulates substrate delivery to NOS. Focus on "Nitric oxide can acutely modulate its biosynthesis through a negative feedback mechanism on L-arginine transport in cardiac myocytes".
    Gatto C
    Am J Physiol Cell Physiol; 2010 Aug; 299(2):C213-5. PubMed ID: 20505043
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of acute rejection on L-arginine/iNOS pathway in canine heart transplantation.
    Demers P; Elkouri S; Sirois MG; Cartier R
    Can J Cardiol; 2003 Mar; 19(4):419-25. PubMed ID: 12704490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts.
    Wildhirt SM; Weis M; Schulze C; Conrad N; Pehlivanli S; Rieder G; Enders G; von Scheidt W; Reichart B
    Circulation; 2001 Sep; 104(12 Suppl 1):I336-43. PubMed ID: 11568079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current.
    Ziolo MT; Harshbarger CH; Roycroft KE; Smith JM; Romano FD; Sondgeroth KL; Wahler GM
    J Mol Cell Cardiol; 2001 Sep; 33(9):1691-9. PubMed ID: 11549347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nitric oxide and heart failure].
    Yoshioka T; Takahashi M; Ikeda U
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():527-30. PubMed ID: 15506442
    [No Abstract]   [Full Text] [Related]  

  • 29. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart.
    Tada H; Thompson CI; Recchia FA; Loke KE; Ochoa M; Smith CJ; Shesely EG; Kaley G; Hintze TH
    Circ Res; 2000 Feb; 86(3):270-4. PubMed ID: 10679477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
    Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction.
    Skarsgard PL; Wang X; McDonald P; Lui AH; Lam EK; McManus BM; van Breemen C; Laher I
    Circulation; 2000 Mar; 101(11):1303-10. PubMed ID: 10725291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure.
    Razavi HM; Hamilton JA; Feng Q
    Pharmacol Ther; 2005 May; 106(2):147-62. PubMed ID: 15866317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanisms of nitric oxide production].
    Ayajiki K; Shinozaki K; Okamura T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():446-50. PubMed ID: 15506424
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiomyopathy: a role for nitric oxide?
    de Belder A; Moncada S
    Int J Cardiol; 1995 Jul; 50(3):263-8. PubMed ID: 8537150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates.
    Jobgen WS; Fried SK; Fu WJ; Meininger CJ; Wu G
    J Nutr Biochem; 2006 Sep; 17(9):571-88. PubMed ID: 16524713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide and glomerulonephritis.
    Cattell V
    Semin Nephrol; 1999 May; 19(3):277-87. PubMed ID: 10226334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Implication of nitrogen oxide producing enzymes in the pathophysiology of fulminant hepatitis].
    Moreau R
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1182-4. PubMed ID: 12520211
    [No Abstract]   [Full Text] [Related]  

  • 38. Vascular changes after cardiopulmonary bypass and ischemic cardiac arrest: roles of nitric oxide synthase and cyclooxygenase.
    Sellke FW
    Braz J Med Biol Res; 1999 Nov; 32(11):1345-52. PubMed ID: 10559835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibition of VSMC proliferation by nitric oxide].
    Sato R; Hirata Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():496-9. PubMed ID: 15506435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.